Objective C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitus (T2DM) patients, whereas its role in coronary artery disease (CAD) has not been clarified, especially in diabetics with differing body mass indices (BMIs). Design and Methods This cross-sectional study included 501 patients with T2DM. First, all subjects were divided into the following two groups: CAD and non-CAD. Then, binary logistic regression was used to determine the risk factors for CAD for all patients. To clarify the role of obesity, we re-divided all subjects into two additional groups (obese and non-obese) based on BMI. Finally, binary logistic regression was used to determine the risk factors for CAD for each weight gro...
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-d...
Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Lev...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitu...
C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitu...
The type 2 diabetes (T2DM) is one of the major risk fac-tors of cardiovascular disease (CVD) which i...
BackgroundRecent studies have revealed that C-peptide induces smooth muscle cell proliferation and c...
Background: The potential role of lipoprotein (a) changes and also inflammation in coronary artery d...
Background: Various cardiovascular disease (CVD) risk factors have been implicated to correlate with...
Objective: Although serum C-peptide has increasingly received attention as a new and important risk ...
We sought association between serum Lipoprotein(a) and C-Peptide levels as two predictors with cardi...
Additional file 1: Table S1. Baseline characteristics and cardiovascular events in the participants ...
BACKGROUND: Diabetes mellitus is a group of metabolic disorders characterised by chronic hyperglyc...
Background Being overweight or obese is associated with a greater risk of coronary heart disease and...
Aims: To study the association between baseline level of C-peptide and all-cause death, cardiovascul...
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-d...
Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Lev...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...
C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitu...
C-peptide has been reported to be a marker of subclinical atherosclerosis in type 2 diabetes mellitu...
The type 2 diabetes (T2DM) is one of the major risk fac-tors of cardiovascular disease (CVD) which i...
BackgroundRecent studies have revealed that C-peptide induces smooth muscle cell proliferation and c...
Background: The potential role of lipoprotein (a) changes and also inflammation in coronary artery d...
Background: Various cardiovascular disease (CVD) risk factors have been implicated to correlate with...
Objective: Although serum C-peptide has increasingly received attention as a new and important risk ...
We sought association between serum Lipoprotein(a) and C-Peptide levels as two predictors with cardi...
Additional file 1: Table S1. Baseline characteristics and cardiovascular events in the participants ...
BACKGROUND: Diabetes mellitus is a group of metabolic disorders characterised by chronic hyperglyc...
Background Being overweight or obese is associated with a greater risk of coronary heart disease and...
Aims: To study the association between baseline level of C-peptide and all-cause death, cardiovascul...
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-d...
Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Lev...
Objective: To quantify the relationship of residual C-peptide secretion to glycemic outcomes and mic...